Major depressive disorder shares immune abnormalities and potential therapies with inflammatory skin diseases

A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...

Single DMT dose treats stress-induced depression more effectively than Prozac in mice

Psychedelics are psychoactive substances that trigger unusual mental states, also referred to as "trips," altering the ...
News Medical on MSN

Brain connectivity fingerprints differ in major depressive disorder

Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve ...
European Medical Journal

Major Depressive Disorder Linked to Poorer Asthma Control

In older adults with asthma, major depressive disorder was linked to poorer control and quality of life, partly via negative ...

Brain 'fingerprints' are less unique in major depressive disorder, study suggests

Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...
Healio

BDNF levels may distinguish depressive symptoms with asthma from major depressive disorder

Patients with depressive symptoms and asthma had elevated levels of serum brain-derived neurotrophic factor in association ...
Monthly Prescribing Reference

Mixed Results for Solriamfetol in MDD Patients W/Wo Excessive Daytime Sleepiness

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...
FiercePharma

Intra-Cellular's Caplyta scores again in major depressive disorder as blockbuster expansion comes within reach

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...